The use of menopausal hormone therapy in women survivors of gynecological cancer: safety report based on systematic reviews and meta-analysis
European Journal of Gynaecological Oncology
The data collected during the last two decades on the effects of Hormonal menopause treatment (HMT) could help to provide a safer and more effective long term-treatment of menopause symptoms and possible complications such as osteoporotic fractures, cognitive impairment, or cardiovascular conditions, as well as an improved quality of life. Having a history of suffering from gynecological cancer (endometrial, cervical or ovarian) is one of the conditions that most strongly determines the use of
... ny form of HMT due to the concerns associated with a possible recurrence of the disease. Objective: to create a set of eligibility criteria for the use of HMT in gynecological cancer patients. Methods: The study was registered in PROSPERO (registration number CRD42020166658). Results: Ovarian cancer survivors who use HMT have better overall survival, disease-free survival, and lower recurrence rates than women survivors who do not use HMT. Endometrial cancer survivors who use HMT do not have a higher rate of disease recurrence than those survivors who do not use HMT. Cervical cancer survivors who use HMT do not have a higher rate of disease recurrence than those survivors who do not use HMT. Conclusion: HMT is safe in women who have suffered from most of non-advanced gynecological cancers.